Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
 

 

Southern Consortium Node


The Southern Consortium Node (formerly the South Carolina Node) comprises five research CTPs in South Carolina and Georgia as well as approximately 25 treatment centers in South Carolina, Georgia and Mississippi, who are members of the Southern Consortium. The consortium was formed to help facilitate promulgation of CTN findings and provide a larger pool of potential CTN research sites. The CTPs of the Southern Consortium provide services to adults and adolescents in both rural and urban areas and represent a wide range of treatment settings and modalities including 12-step, family therapy, medication management, inpatient detoxification, drug court, narcotic replacement therapy, and cognitive behavioral therapy.

 

Regional Research and Training Center

Medical University of South Carolina
Department of Psychiatry
Clinical Neuroscience Division
67 President Street
Charleston, SC 29425

Principal Investigator

Kathleen T. Brady, M.D., Ph.D.
Professor of Psychiatry
Medical University of South Carolina
Department of Psychiatry
67 President Street, P.O. Box 250861
Charleston, SC 29425
843-792-5215 (Voice)
bradyk@musc.edu

Community Treatment Programs

Behavioral Health Services of Pickens County
Pickens, SC

Charleston Center
Charleston, SC

Dorchester Alcohol and Drug Commission
Summerville, SC

Grady Drug Dependency Unit
Atlanta, GA

Lexington/Richland Alcohol and Drug Council
Columbia, SC

University of Mississippi Medical Center
Jackson, MS

VA Medical Center-Atlanta
Decatur, GA

Southern Consortium Protocol Involvement
PROTOCOL0006 Motivational Incentives - Drug Free Clinics
PROTOCOL0008 A Baseline for Investigating Diffusion of Innovation
PROTOCOL0009 Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy In Substance Abuse Rehabilitation Programs
PROTOCOL0011 A Feasibility Study of a Telephone Enhancement Procedure (TELE) to Improve Participation in Continuing Care Activities
PROTOCOL0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
PROTOCOL0015 Women's Treatment for Trauma and Substance Use Disorders
PROTOCOL0016 Patient Feedback : A Performance Improvement Study in Outpatient Addiction Treatment
PROTOCOL0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
PROTOCOL0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment
PROTOCOL0020 Job-Seekers Training for Patients with Drug Dependence
PROTOCOL0028 Osmotic-Release Methylphenidate for ADHD in Adolescents with Substance Use Disorders
PROTOCOL0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
PROTOCOL0032 HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S.



 

 



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment |


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, July 9, 2008. The U.S. government's official web portal